Photo via Reason

Hazy Drug Classification Criteria Invite Dubious Bureaucratic Judgments

Read the original at Reason ↗
Cite

Sullum, J. (2026, September 30). Hazy Drug Classification Criteria Invite Dubious Bureaucratic Judgments. Reason. https://reason.com/2026/09/30/hazy-federal-criteria-for-classifying-drugs-invite-arbitrary-bureaucratic-judgments/

Dated when The Aporia collected the article, usually within hours of publication. Check the original for its exact date and byline.

Reason · collected 2026-09-30 · by Jacob Sullum

Quick Summary

The article discusses how vague criteria in the Controlled Substances Act (CSA) allow for ambiguous drug classifications by bureaucratic agencies like the DEA and HHS. The CSA categorizes drugs into five schedules based on their potential for abuse and medical use, but these terms are not clearly defined. This ambiguity has led to inconsistent classification decisions, such as the long-standing debate over marijuana's placement in Schedule I despite growing evidence of its medical benefits. Recent shifts during the Biden administration suggest a move towards reclassifying cannabis into Schedule III, though this remains subject to further regulatory scrutiny and interpretation.
Written by AI on 2026-09-30, from this article's own text only (the story summary below draws on all the coverage).

AI analysis

Story summary

The Controlled Substances Act (CSA), enacted by Congress in 1970, established a system for classifying drugs based on their "medical use" and "potential for abuse." However, the statute does not clearly define these criteria, leading to debatable and changeable regulatory judgments. The Drug Enforcement Administration (DEA) placed marijuana in Schedule I under this act, categorizing it alongside heroin, LSD, psilocybin, and MDMA as having a high potential for abuse with no currently accepted medical use or safety for use under medical supervision. This classification has significant criminal justice implications despite ongoing petitions arguing that marijuana does not meet the statutory criteria for such placement.

Written for “Drug Policy Ambiguity” on 2026-11-18, grounded in this article and the 0 other(s) covering the same event.

Compared with similar articles

This article reads unscored and hedges 0% of its claims. Each row says how that neighbour differs.
Toronto Star
Leans strongly left Hedges 1 of 30 claims Outlet record 64/100
“The articles discuss different topics: one about drug classification criteria and bureaucratic judgments, while the other is about a court decision regarding founders of an organization in Canada.”
Toronto Star
Hedges 5 of 52 claims Outlet record 64/100
“The articles discuss different topics; one focuses on the ambiguity in drug classification criteria under the Controlled Substances Act, while the other reports on a pharmacist's misconduct and loss of license.”
Reason
Hedges 1 of 33 claims Outlet record 67/100
“Both articles discuss the same topic, the scheduling system of drugs regulated by the DEA and FDA, but they do not describe a single specific event or incident.”

Story

Drug Policy Ambiguity
Politics · 1 article(s) covering the same event.
How this article was measured signals, leaning charts, publisher record, byline, topics and claims

Signals How these are calculated →

Claims extracted
24
sentences that state something as happening or true
Uncertain
0%
0 of 24 hedged ("reportedly", "may", "according to")
Leaning
withheld
no quote in the article backed the model's score
Publisher signals
67/100
Reason's corrections and hedging, across everything collected from it. Not a measure of accuracy.
Outlets on this story
1
Politics
Same framing elsewhere
1
articles that frame the event the way this one does
Analyzed 2026-09-30 · how these are computed

How this is being covered How these are calculated →

Article leaning vs. publisher reliability
Source leaning vs. consistency

Publisher

Reason · 1377 article(s) · 4 correction(s) detected
Running correction rate · 4 correction(s)

Who wrote this

Jacob Sullum
45 article(s) here · 1 carrying a prediction
Contrary to the implication of that label, the initiative affected many people who had no criminal convictions that would justify revoking their visas.
Trump also averred that his projects do not involve much money, although the ballroom alone is expected to cost around $600 million, half of which will be covered by taxpayers.
Last week, the city of Delray Beach, Florida, announced that it will not organize or sponsor next year's St. Patrick's Day parade, citing a state law that takes effect on January 1.
That means SSJC members cannot even legally transport their guns to the vicinity of the synagogue on those occasions, since they would pass within 300 feet of parks, schools, and other houses of worship while walking there.
In a 60 Minutes interview that aired on Sunday night, President Donald Trump conceded that his mass deportation campaign may have contributed to the Republican rout in last week's midterm elections because "a lot of people think it's too tough."
2026-11-11 · assertive framing · Trump Debates Mass Deportation With Himself
They say Hegseth is flouting the law, undermining basic principles of justice, and perverting the mission of the U.S. military by treating civilians as combatants who can be killed at will, from a distance and in cold blood, without any semblance of due process.
Attorney General Todd Blanche nevertheless seemed to reinforce Trump's threat during an interview on CNN's State of the Union yesterday, saying members of the House Oversight Committee, which will be chaired by Rep. Robert Garcia (D–Calif.) in the next congressional session, should "be very worried."
President Donald Trump today announced that Stephen Miller will replace Susie Wiles as White House chief of staff.
Like many other police officers in New Mexico, Paul Jessen Jr., a Bernalillo County sheriff's deputy, was willing to accept bribes from Albuquerque defense attorney Thomas J. Clear III in exchange for compromising DWI cases against Clear's clients.
These results might be dismissed as anomalous, the product of anger at the party of an unpopular president whose war, tariff, and deportation policies, combined with his constant self-aggrandizement and presidential profiteering, alienated Americans who otherwise might have voted for Republicans.
Also by Jacob Sullum
Nothing else under this byline is closely related to this article, so these are simply their most recent.
All 45 articles by Jacob Sullum →

Topics

Congress DEA FDA GAO HHS

Subjects

FDA ORG · 5× HHS ORG · 4× DEA ORG · 3× GAO ORG · 3× Congress ORG · 2× Biden PERSON · 1× the Department of Health and Human Services ORG · 1× the Drug Enforcement Administration ORG · 1× the Food and Drug Administration ORG · 1× the Government Accountability Office ORG · 1×

Narrative

When Congress enacted the CSA in 1970, it placed marijuana in Schedule I, and the Drug Enforcement Administration (DEA), which had the authority to reclassify drugs in consultation with the Department of Health and Human Services (HHS), kept it there, rejecting a series of petitions arguing that it did not meet the statutory criteria.
framing: assertive · carried by 1 article(s) · first seen 2026-09-30
For the time being, he said, only marijuana products currently sold by state-licensed medical dispensaries or approved in the future by the FDA would qualify for Schedule III.

Claims (24 extracted, 0 hedged)

Half a century ago, Congress approved the Controlled Substances Act (CSA), which established a system for classifying drugs based on their "medical use" and "potential for abuse." asserted
which → approve → abuse
But as a recent report from the Government Accountability Office (GAO) notes, the statute does not clearly define either criterion, opening the door to debatable and changeable regulatory judgments with far-reaching criminal justice implications. asserted
statute → note → implications
Schedule I of the CSA is supposedly reserved for drugs that have "a high potential for abuse," "no currently accepted medical use," and "no accepted safety for use under medical supervision." asserted
that → reserve → supervision
Those drugs, which include heroin, LSD, psilocybin, and MDMA, are prohibited except for government-approved research purposes. asserted
which → include → purposes
Schedule II drugs, which include cocaine, methamphetamine, fentanyl, morphine, hydrocodone, and oxycodone, also are deemed to have "a high potential for abuse." asserted
which → include → abuse
But their medical use is "accepted," and they are legally available by prescription. asserted
they → accept → prescription
So are drugs in Schedules III, IV, and V, which are supposed to have progressively lower abuse potential, justifying less severe criminal penalties for unauthorized possession and distribution. asserted
which → suppose → possession
Right away we see a problem: A drug with "potential for abuse" short of "high" but no "accepted" medical use does not fit into any of these schedules. asserted
drug → see → schedules
The historical treatment of cannabis illustrates that puzzle. asserted
treatment → illustrate → puzzle
When Congress enacted the CSA in 1970, it placed marijuana in Schedule I, and the Drug Enforcement Administration (DEA), which had the authority to reclassify drugs in consultation with the Department of Health and Human Services (HHS), kept it there, rejecting a series of petitions arguing that it did not meet the statutory criteria. asserted
it → enact → criteria
Beginning in 1992, the GAO notes, the DEA defined "accepted medical use" based on five criteria, including "adequate safety studies" and "adequate and well-controlled studies proving efficacy." asserted
DEA → begin → efficacy
Since those requirements are similar to the evidence that the Food and Drug Administration (FDA) demands to approve a drug for prescription use, the DEA's definition essentially equated "accepted medical use" with FDA approval. asserted
definition → demand → approval
During the Biden administration, the HHS embraced an alternative test for "accepted medical use" that considers "widespread" clinical experience with a drug (in the 41 states that have legalized medical marijuana, for example) and requires "some credible scientific support" for at least one application. asserted
that → embrace → application
Based on an FDA analysis, HHS said cannabis passed that test and, after reconsidering its "potential for abuse," recommended placing it in Schedule III, which includes prescription drugs such as ketamine, anabolic steroids, and Tylenol with codeine. asserted
which → base → codeine
Last April, Acting Attorney General Todd Blanche issued a final rule that followed the HHS recommendation, but with a twist. asserted
that → issue → twist
For the time being, he said, only marijuana products currently sold by state-licensed medical dispensaries or approved in the future by the FDA would qualify for Schedule III. asserted
products → say → Schedule
The scientific and legal logic of that decision was hard to follow, since the included and excluded products are pharmacologically identical, distinguished only by their intended use. asserted
products → follow → use
By contrast, cocaine, fentanyl, and methamphetamine are all Schedule II drugs, regardless of whether they are dispensed by pharmacies based on medical prescriptions or purchased on the black market without legal authorization. asserted
they → dispense → authorization
In any event, the government's reversal on cannabis showed how malleable the CSA's scheduling criteria are. asserted
criteria → show → cannabis
The drug's reclassification hinged on a change in attitude rather than a change in the underlying science. asserted
reclassification → hinge → science
In addition to a redefinition of "accepted medical use," that shift entailed a new assessment of marijuana's abuse potential. asserted
shift → accept → potential
The CSA "does not include a statutory definition of 'potential for abuse,'" the GAO notes, and "FDA officials told us that the lack of a written definition…presented challenges for determining the relative abuse potential and appropriate schedule recommendation for some substances." asserted
lack → include → substances
The GAO thinks the FDA should specify "the criteria and process for determining a substance's 'potential for abuse.'" asserted
FDA → think → abuse
The lack of clarity highlighted by the report is astonishing, given how long Americans have been living with the CSA, which criminalizes a wide range of peaceful conduct and prescribes penalties based on arbitrary bureaucratic distinctions. asserted
which → highlight → distinctions
Give feedback · no sign-in needed

No sign-in needed for now. Your note is sent without a name, so it cannot be answered.

History Support